Figure 1

Study protocol. Blood pressure was targeted at <130/80 mm Hg during the study period. HCTZ, hydrochlorothiazide; LS, losartan; RAS, renin–angiotensin system.
Study protocol. Blood pressure was targeted at <130/80 mm Hg during the study period. HCTZ, hydrochlorothiazide; LS, losartan; RAS, renin–angiotensin system.